AAAAAA

   
Results: 1-25 | 26-43
Results: 1-25/43

Authors: Matsumoto, N Tamura, S Moser, A Moser, HW Braverman, N Suzuki, Y Shimozawa, N Kondo, N Fujiki, Y
Citation: N. Matsumoto et al., The peroxin Pex6p gene is impaired in peroxisomal biogenesis disorders of complementation group 6, J HUM GENET, 46(5), 2001, pp. 273-277

Authors: Berger, J Moser, HW Forss-Petter, S
Citation: J. Berger et al., Leukodystrophies: recent developments in genetics, molecular biology, pathogenesis and treatment, CURR OP NEU, 14(3), 2001, pp. 305-312

Authors: Watkins, PA Hamilton, JA Leaf, A Spector, AA Moore, SA Anderson, RE Moser, HW Noetzel, MJ Katz, R
Citation: Pa. Watkins et al., Brain uptake and utilization of fatty acids - Applications to peroxisomal biogenesis diseases, J MOL NEURO, 16(2-3), 2001, pp. 87-92

Authors: Faust, PL Su, HM Moser, A Moser, HW
Citation: Pl. Faust et al., The peroxisome deficient PEX2 Zellweger mouse - Pathologic and biochemicalcorrelates of lipid dysfunction, J MOL NEURO, 16(2-3), 2001, pp. 289-297

Authors: Katz, R Hamilton, JA Spector, AA Moore, SA Moser, HW Noetzel, MJ Watkins, PA
Citation: R. Katz et al., Brain uptake and utilization of fatty acids - Recommendations for future research, J MOL NEURO, 16(2-3), 2001, pp. 333-335

Authors: Bezman, L Moser, AB Raymond, GV Rinaldo, P Watkins, PA Smith, KD Kass, NE Moser, HW
Citation: L. Bezman et al., Adrenoleukodystrophy: Incidence, new mutation rate, and results of extended family screening, ANN NEUROL, 49(4), 2001, pp. 512-517

Authors: Powers, JM Rosenblatt, DS Schmidt, RE Cross, AH Black, JT Moser, AB Moser, HW Morgan, DJ
Citation: Jm. Powers et al., Neurological and neuropathologic heterogeneity in two brothers with cobalamin C deficiency, ANN NEUROL, 49(3), 2001, pp. 396-400

Authors: van Geel, BM Bezman, L Loes, DJ Moser, HW Raymond, GV
Citation: Bm. Van Geel et al., Evolution of phenotypes in adult male patients with X-linked adrenoleukodystrophy, ANN NEUROL, 49(2), 2001, pp. 186-194

Authors: Melhem, ER Gotwald, TF Itoh, R Zinreich, SJ Moser, HW
Citation: Er. Melhem et al., T2 relaxation measurements in X-linked adrenoleukodystrophy performed using dual-echo fast fluid-attenuated inversion recovery MR imaging, AM J NEUROR, 22(4), 2001, pp. 773-776

Authors: Ito, R Melhem, ER Mori, S Eichler, FS Raymond, GV Moser, HW
Citation: R. Ito et al., Diffusion tensor brain MR imaging in X-linked cerebral adrenoleukodystrophy, NEUROLOGY, 56(4), 2001, pp. 544-547

Authors: Powers, JM DeCiero, DP Cox, C Richfield, EK Ito, M Boser, AB Moser, HW
Citation: Jm. Powers et al., The dorsal root ganglia in adrenomyeloneuropathy: Neuronal atrophy and abnormal mitochondria, J NE EXP NE, 60(5), 2001, pp. 493-501

Authors: Ito, M Blumberg, BM Mock, DJ Goodman, AD Moser, AB Moser, HW Smith, KD Powers, JM
Citation: M. Ito et al., Potential environmental and host participants in the early white matter lesion of adreno-leukodystrophy: Morphologic evidence for CD8 cytotoxic T cells, cytolysis of oligodendrocytes, and CD1-mediated lipid antigen presentation, J NE EXP NE, 60(10), 2001, pp. 1004-1019

Authors: Williard, DE Nwankwo, JO Kaduce, TL Harmon, SD Irons, M Moser, HW Raymond, GV Spector, AA
Citation: De. Williard et al., Identification of a fatty acid Delta(6)-desaturase deficiency in human skin fibroblasts, J LIPID RES, 42(4), 2001, pp. 501-508

Authors: Su, HM Moser, AB Moser, HW Watkins, PA
Citation: Hm. Su et al., Peroxisomal straight-chain acyl-CoA oxidase and D-bifunctional protein areessential for the retroconversion step in docosahexaenoic acid synthesis, J BIOL CHEM, 276(41), 2001, pp. 38115-38120

Authors: Moser, HW Raymond, GV
Citation: Hw. Moser et Gv. Raymond, Docosahexaenoic acid therapy for disorders of peroxisome biogenesis, NUTR HLTH, 2001, pp. 257-271

Authors: Moser, HW
Citation: Hw. Moser, Molecular genetics of peroxisomal disorders, FRONT BIOSC, 5, 2000, pp. D298-D306

Authors: Lachtermacher, MBR Seuanez, HN Moser, AB Moser, HW Smith, KD
Citation: Mbr. Lachtermacher et al., Determination of 30 X-linked adrenoleukodystrophy mutations, including 15 not previously described, HUM MUTAT, 15(4), 2000, pp. 348-353

Authors: Kaufmann, WE Moser, HW
Citation: We. Kaufmann et Hw. Moser, Dendritic anomalies in disorders associated with mental retardation, CEREB CORT, 10(10), 2000, pp. 981-991

Authors: Lachtermacher, MBR Seuanez, HN Moser, HW Smith, KD
Citation: Mbr. Lachtermacher et al., One-step multiplex PCR strategy for identification of mutations by SSCP and DNA sequencing, BIOTECHNIQU, 29(2), 2000, pp. 234

Authors: Yeager, AM Uhas, KA Coles, CD Davis, PC Krause, WL Moser, HW
Citation: Am. Yeager et al., Bone marrow transplantation for infantile ceramidase deficiency (Farber disease), BONE MAR TR, 26(3), 2000, pp. 357-363

Authors: Santos, MJ Henderson, SC Moser, AB Moser, HW Lazarow, PB
Citation: Mj. Santos et al., Peroxisomal ghosts are intracellular structures distinct from lysosomal compartments in Zellweger Syndrome: A confocal laser scanning microscopy study, BIO CELL, 92(2), 2000, pp. 85-94

Authors: Melhem, ER Loes, DJ Georgiades, CS Raymond, GV Moser, HW
Citation: Er. Melhem et al., X-linked adrenoleukodystrophy: The role of contrast-enhanced MR imaging inpredicting disease progression, AM J NEUROR, 21(5), 2000, pp. 839-844

Authors: Moser, HW Loes, DJ Melhem, ER Raymond, GV Bezman, L Cox, CS Lu, SE
Citation: Hw. Moser et al., X-linked adrenoleukodystrophy: Overview and prognosis as a function of ageand brain magnetic resonance imaging abnormality. A study involving 372 patients, NEUROPEDIAT, 31(5), 2000, pp. 227-239

Authors: Moser, HW Bezman, L Lu, SE Raymond, GV
Citation: Hw. Moser et al., Therapy of X-linked adrenoleukodystrophy: Prognosis based upon age and MRIabnormality and plans for placebo-controlled trials, J INH MET D, 23(3), 2000, pp. 273-277

Authors: Powers, JM DeCiero, DP Ito, M Moser, AB Moser, HW
Citation: Jm. Powers et al., Adrenomyeloneuropathy: A neuropathologic review featuring its noninflammatory myelopathy, J NE EXP NE, 59(2), 2000, pp. 89-102
Risultati: 1-25 | 26-43